Cargando…

T.08.5 THE OVERALL SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) PANDEMIC IMPACT ON METABOLIC (DYSFUNCTION) ASSOCIATED FATTY LIVER DISEASE. A PRELIMINARY EVALUATION

Detalles Bibliográficos
Autores principales: Romeo, M., Dallio, M., Cipullo, M., Olivieri, S., Iadanza, G., Sangineto, M., Ventriglia, L., Scognamiglio, F., Federico, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065947/
http://dx.doi.org/10.1016/S1590-8658(22)00448-0
_version_ 1784699700817952768
author Romeo, M.
Dallio, M.
Cipullo, M.
Olivieri, S.
Iadanza, G.
Sangineto, M.
Ventriglia, L.
Scognamiglio, F.
Federico, A.
author_facet Romeo, M.
Dallio, M.
Cipullo, M.
Olivieri, S.
Iadanza, G.
Sangineto, M.
Ventriglia, L.
Scognamiglio, F.
Federico, A.
author_sort Romeo, M.
collection PubMed
description
format Online
Article
Text
id pubmed-9065947
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-90659472022-05-04 T.08.5 THE OVERALL SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) PANDEMIC IMPACT ON METABOLIC (DYSFUNCTION) ASSOCIATED FATTY LIVER DISEASE. A PRELIMINARY EVALUATION Romeo, M. Dallio, M. Cipullo, M. Olivieri, S. Iadanza, G. Sangineto, M. Ventriglia, L. Scognamiglio, F. Federico, A. Dig Liver Dis Poster Presentations Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. 2022-05 2022-05-04 /pmc/articles/PMC9065947/ http://dx.doi.org/10.1016/S1590-8658(22)00448-0 Text en © 2022 Editrice Gastroenterologica Italiana S.r.l. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Poster Presentations
Romeo, M.
Dallio, M.
Cipullo, M.
Olivieri, S.
Iadanza, G.
Sangineto, M.
Ventriglia, L.
Scognamiglio, F.
Federico, A.
T.08.5 THE OVERALL SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) PANDEMIC IMPACT ON METABOLIC (DYSFUNCTION) ASSOCIATED FATTY LIVER DISEASE. A PRELIMINARY EVALUATION
title T.08.5 THE OVERALL SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) PANDEMIC IMPACT ON METABOLIC (DYSFUNCTION) ASSOCIATED FATTY LIVER DISEASE. A PRELIMINARY EVALUATION
title_full T.08.5 THE OVERALL SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) PANDEMIC IMPACT ON METABOLIC (DYSFUNCTION) ASSOCIATED FATTY LIVER DISEASE. A PRELIMINARY EVALUATION
title_fullStr T.08.5 THE OVERALL SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) PANDEMIC IMPACT ON METABOLIC (DYSFUNCTION) ASSOCIATED FATTY LIVER DISEASE. A PRELIMINARY EVALUATION
title_full_unstemmed T.08.5 THE OVERALL SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) PANDEMIC IMPACT ON METABOLIC (DYSFUNCTION) ASSOCIATED FATTY LIVER DISEASE. A PRELIMINARY EVALUATION
title_short T.08.5 THE OVERALL SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) PANDEMIC IMPACT ON METABOLIC (DYSFUNCTION) ASSOCIATED FATTY LIVER DISEASE. A PRELIMINARY EVALUATION
title_sort t.08.5 the overall severe acute respiratory syndrome coronavirus 2 (sars-cov-2) pandemic impact on metabolic (dysfunction) associated fatty liver disease. a preliminary evaluation
topic Poster Presentations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065947/
http://dx.doi.org/10.1016/S1590-8658(22)00448-0
work_keys_str_mv AT romeom t085theoverallsevereacuterespiratorysyndromecoronavirus2sarscov2pandemicimpactonmetabolicdysfunctionassociatedfattyliverdiseaseapreliminaryevaluation
AT dalliom t085theoverallsevereacuterespiratorysyndromecoronavirus2sarscov2pandemicimpactonmetabolicdysfunctionassociatedfattyliverdiseaseapreliminaryevaluation
AT cipullom t085theoverallsevereacuterespiratorysyndromecoronavirus2sarscov2pandemicimpactonmetabolicdysfunctionassociatedfattyliverdiseaseapreliminaryevaluation
AT olivieris t085theoverallsevereacuterespiratorysyndromecoronavirus2sarscov2pandemicimpactonmetabolicdysfunctionassociatedfattyliverdiseaseapreliminaryevaluation
AT iadanzag t085theoverallsevereacuterespiratorysyndromecoronavirus2sarscov2pandemicimpactonmetabolicdysfunctionassociatedfattyliverdiseaseapreliminaryevaluation
AT sanginetom t085theoverallsevereacuterespiratorysyndromecoronavirus2sarscov2pandemicimpactonmetabolicdysfunctionassociatedfattyliverdiseaseapreliminaryevaluation
AT ventriglial t085theoverallsevereacuterespiratorysyndromecoronavirus2sarscov2pandemicimpactonmetabolicdysfunctionassociatedfattyliverdiseaseapreliminaryevaluation
AT scognamigliof t085theoverallsevereacuterespiratorysyndromecoronavirus2sarscov2pandemicimpactonmetabolicdysfunctionassociatedfattyliverdiseaseapreliminaryevaluation
AT federicoa t085theoverallsevereacuterespiratorysyndromecoronavirus2sarscov2pandemicimpactonmetabolicdysfunctionassociatedfattyliverdiseaseapreliminaryevaluation